- Home
- LBRDP vs RVPHW Comparison
LBRDP vs RVPHW Comparison
Compare LBRDP & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDP
- RVPHW
- Stock Information
- Founded
- LBRDP N/A
- RVPHW N/A
- Country
- LBRDP United States
- RVPHW United States
- Employees
- LBRDP 1900
- RVPHW 15
- Industry
- LBRDP Cable & Other Pay Television Services
- RVPHW Biotechnology: Pharmaceutical Preparations
- Sector
- LBRDP Telecommunications
- RVPHW Health Care
- Exchange
- LBRDP Nasdaq
- RVPHW Nasdaq
- Market Cap
- LBRDP N/A
- RVPHW N/A
- IPO Year
- LBRDP N/A
- RVPHW 2018
- Fundamental
- Price
- LBRDP $24.29
- RVPHW $0.09
- Analyst Decision
- LBRDP
- RVPHW
- Analyst Count
- LBRDP 0
- RVPHW 0
- Target Price
- LBRDP N/A
- RVPHW N/A
- AVG Volume (30 Days)
- LBRDP N/A
- RVPHW N/A
- Earning Date
- LBRDP N/A
- RVPHW N/A
- Dividend Yield
- LBRDP N/A
- RVPHW N/A
- EPS Growth
- LBRDP N/A
- RVPHW N/A
- EPS
- LBRDP N/A
- RVPHW N/A
- Revenue
- LBRDP N/A
- RVPHW N/A
- Revenue This Year
- LBRDP N/A
- RVPHW N/A
- Revenue Next Year
- LBRDP N/A
- RVPHW N/A
- P/E Ratio
- LBRDP N/A
- RVPHW N/A
- Revenue Growth
- LBRDP N/A
- RVPHW N/A
- 52 Week Low
- LBRDP N/A
- RVPHW N/A
- 52 Week High
- LBRDP N/A
- RVPHW N/A
- Technical
- Relative Strength Index (RSI)
- LBRDP 53.79
- RVPHW N/A
- Support Level
- LBRDP $23.95
- RVPHW N/A
- Resistance Level
- LBRDP $24.85
- RVPHW N/A
- Average True Range (ATR)
- LBRDP 0.40
- RVPHW 0.00
- MACD
- LBRDP -0.07
- RVPHW 0.00
- Stochastic Oscillator
- LBRDP 43.40
- RVPHW 0.00
About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.